About David Gerber
Form D filings for BioMedInnovations in 2024 list David Gerber as executive officer.
David Gerber first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name David Gerber in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Gerber works with at each company, as listed on that company's latest Form D.
BioMedInnovations LLC · Form D, Apr 10, 2024
EF
Elizabeth Flanary
Director
GB
George Barr
Director
RN
Robert Neusner
Chief Operating and Business Officer
CD
Carrie DiMarzio
Executive officer and director